← All verdicts
Verdict

Deep Overvalued

Every analyzed stock in Deep Overvalued1,218 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
"Deep Overvalued" by: Model value (price vs DCF) Owner-earnings return (equity bond)

This lens: price against our probability-weighted DCF value (P/IV). Its own forward record began accruing on 2026-09-10 (daily snapshots); until a year of it exists, the panel below tests the nearest cousin we can measure point-in-time — cheap on book value — and says so.

Market state today: Calm — the S&P 500 closed 2.0% below its 1-year high (as of 2026-09-17). Our rule, the same one used to split every backtest on this site: sell-off = 10% or more below the 1-year high, borderline from 5%, calm otherwise. A further 8.2% fall from here would put us in a sell-off. Since 2006 the market has been in a sell-off 16.6% of the time, across 13 episodes (red bands).
2007200920112013201520172019202120232025
S&P 500 (SPY, adjusted) distance from its trailing 1-year high, weekly. Amber band: borderline (−5% to −10%). Red band: sell-off (below −10%). The dot is today. History to 2026-08-19 from the research database; today from the live feed.
Backtest · point in time · 8,702 entries in the study

Does this screen work? The record for exactly these filters

Screen tested: Proxy: price-to-book ≤ 1.2 (undervalued band has no point-in-time history yet) · bought the day of the annual report, held 12 months
Probable Buy every company that met this screen on the day it filed its annual report, hold 12 months: on average it beat the S&P 500 by +12.6 pts (1,427 entries, 311 companies, very unlikely to be luck). 50% of entries beat the S&P; 25% beat it by 30 points or more; 30% trailed it by 20 points or more. Owning everything instead averaged +1.7 pts, so the screen's edge is +10.9 pts.
+12.6 ptsvs S&P, average
50%beat the S&P
25%up 30+ pts vs S&P
30%down 20+ pts vs S&P
+14.0 ptsvs small caps, 12 mo
−15.1 pts 2019worst year to buy ?
6.1luck check ?
Does the holding period matter?3 mo: +2.3 pts 49% beat6 mo: +4.6 pts 49% beat12 mo: +12.6 pts 50% beat24 mo: +21.8 pts 46% beat3 yr, per yr: +1.3 pts 40% beat
Market state at entryCompany-yearsvs S&P 12 movs small caps
Calm ◀ today1,245+7.9 pts t 4.6+10.1 pts
Sell-off (S&P ≥10% off high)182+44.5 pts t 4.0+40.7 pts
Sector (SEC group)nvs S&P 12 mo3 yrs / yr
Industrials & manufacturing466+13.0 pts t 4.0−2.2 pts
Energy126+7.4 pts t 1.2−7.8 pts
Other115+8.4 pts t 1.8+3.8 pts
Tech hardware & semis113+10.9 pts t 1.6+2.3 pts
Services96+11.9 pts t 2.7+12.2 pts
Retail & consumer87+17.2 pts t 2.1+10.2 pts
Finance & real estate72−1.7 pts t -0.5−2.4 pts
Utilities65+5.6 pts t 0.6−1.2 pts
Construction53+13.2 pts t 1.7−2.4 pts
Biotech & pharma44+47.1 pts t 1.6+10.0 pts
Telecom & media43+14.0 pts t 0.7−6.3 pts
Software & IT services35+39.9 pts t 1.8+1.2 pts

Holds up out of sample? Before 2018: +10.7 pts (n 629, t 6.0). From 2018: +14.0 pts (n 798, t 4.1). Same sign in both halves.

Year2010201120122013201420152016201720182019202020212022202320242025
vs S&P+13 pts+5 pts+14 pts+18 pts−4 pts−4 pts+22 pts+12 pts−3 pts−15 pts+87 pts+8 pts+17 pts−9 pts−7 pts+15 pts
n254310610178841118178991297276108121115

Read the research behind this screen: Price-to-book still sorts, across all sizes → · Test your own combination in the Screen Lab →

Our model values are recomputed daily but were never stored historically, so this band cannot be backtested honestly yet. Daily snapshots began 2026-09-10; a true record accrues from there. Until then the nearest tested cousin is shown — cheap on book value — and labelled as a proxy. Point-in-time: each entry is one company bought at the first close after its 10-K filing date, using only filings available that day, held 12 months; result = total return minus SPY over the same months (vs IWM for 12 months; 3-yr annualised). Survivorship-tilted universe; no costs; read spreads, not levels. Educational, hypothetical, before costs.

VCEL
Vericel Corp
Deeply overvalued
Healthcare Risk 61 · High
Price$39.60
Model IV$10.16
P/IV3.28
Premium +290% Return to IV: -74.3%
Market implies +17.2%/yr vs model +15.9% · in line
VCYT
VERACYTE, INC.
Deeply overvalued
Healthcare Risk 60 · High
Price$40.87
Model IV$26.84
P/IV1.73
Premium +52% Return to IV: -34.3%
Market implies +21.2%/yr vs model +19.7% · in line
VEEE
Twin Vee PowerCats, Co.
Deeply overvalued
Consumer Cyclical Risk 50 · Elevated
Price$9.36
Model IV$3.18
P/IV2.26
Premium +194% Return to IV: -66.0%
Market implies +4.8%/yr vs model +2.0% · in line
VFC
V F CORP
Deeply overvalued
Consumer Cyclical Risk 56 · Elevated
Price$13.17
Model IV$10.13
P/IV1.70
Premium +30% Return to IV: -23.1%
Market implies +2.0%/yr vs model -1.2% · above model
VG
Venture Global, Inc.
Deeply overvalued
Utilities Risk 62 · High
Price$15.80
Model IV$6.13
P/IV1.97
Premium +158% Return to IV: -61.2%
VHC
VirnetX Holding Corp
Deeply overvalued
Financial Services Risk 62 · High
Price$11.50
Model IV$3.88
P/IV4.50
Premium +197% Return to IV: -66.3%
VHI
VALHI INC /DE/
Deeply overvalued
Basic Materials Risk 65 · High
Price$18.26
Model IV$4.17
P/IV3.41
Premium +338% Return to IV: -77.2%
Market implies +17.8%/yr vs model +0.0% · above model
VIOT
Viomi Technology Co., Ltd
Deeply overvalued
Technology Risk 59 · Elevated
Price$1.40
Model IV$0.33
P/IV2.91
Premium +322% Return to IV: -76.3%
Market implies +9.2%/yr vs model -9.0% · above model
VISN
Vistance Networks, Inc.
Deeply overvalued
Technology Risk 65 · High
Price$6.48
Model IV$3.58
P/IV3.48
Premium +81% Return to IV: -44.8%
Market implies +1.2%/yr vs model -10.0% · above model
VIVK
Vivakor, Inc.
Valuation N/A
Utilities Risk 36 · Moderate
Price$0.79
Model IV
P/IV
Limited data — see page
VMI
VALMONT INDUSTRIES INC
Deeply overvalued
Industrials Risk 50 · Elevated
Price$483.44
Model IV$202.10
P/IV2.57
Premium +139% Return to IV: -58.2%
Market implies +16.3%/yr vs model +4.9% · above model
VNDA
Vanda Pharmaceuticals Inc.
Deeply overvalued
Healthcare Risk 62 · High
Price$5.09
Model IV$2.13
P/IV3.03
Premium +139% Return to IV: -58.2%
Market implies +9.5%/yr vs model +2.0% · above model
VNO
VORNADO REALTY TRUST
Deeply overvalued
Financial Services Risk 58 · Elevated
Price$35.44
Model IV$6.80
P/IV4.96
Premium +421% Return to IV: -80.8%
VRCA
Verrica Pharmaceuticals Inc.
Deeply overvalued
Healthcare Risk 57 · Elevated
Price$4.91
Model IV$3.47
P/IV1.66
Premium +42% Return to IV: -29.4%
Market implies +8.7%/yr vs model +31.2% · below model
VRDN
Viridian Therapeutics, Inc.DE
Deeply overvalued
Healthcare Risk 57 · Elevated
Price$21.24
Model IV$4.37
P/IV4.03
Premium +386% Return to IV: -79.4%
Market implies +20.6%/yr vs model +50.0% · below model
VRNS
VARONIS SYSTEMS INC
Deeply overvalued
Technology Risk 56 · Elevated
Price$45.12
Model IV$10.10
P/IV3.38
Premium +347% Return to IV: -77.6%
Market implies +25.5%/yr vs model +12.4% · above model
VRT
Vertiv Holdings Co
Deeply overvalued
Technology Risk 59 · Elevated
Price$237.39
Model IV$75.46
P/IV4.18
Premium +215% Return to IV: -68.2%
Market implies +31.4%/yr vs model +17.3% · above model
VRTS
VIRTUS INVESTMENT PARTNERS, INC.
Deeply overvalued
Financial Services Risk 56 · Elevated
Price$147.41
Model IV$65.20
P/IV2.19
Premium +126% Return to IV: -55.8%
Market implies +9.9%/yr vs model +2.0% · above model
VRTX
VERTEX PHARMACEUTICALS INC / MA
Deeply overvalued
Healthcare Risk 64 · High
Price$519.51
Model IV$284.74
P/IV1.57
Premium +82% Return to IV: -45.2%
Market implies +16.9%/yr vs model +11.5% · above model
VS
Versus Systems Inc.
Deeply overvalued
Technology Risk 54 · Elevated
Price$1.13
Model IV$0.89
P/IV1.67
Premium +28% Return to IV: -21.7%
Market implies -3.1%/yr vs model +15.0% · below model
VSCO
Victoria's Secret & Co.
Deeply overvalued
Consumer Cyclical Risk 52 · Elevated
Price$88.68
Model IV$31.07
P/IV1.77
Premium +185% Return to IV: -65.0%
Market implies +20.1%/yr vs model +5.0% · above model
VSEC
VSE CORP
Deeply overvalued
Industrials Risk 59 · Elevated
Price$194.98
Model IV$61.78
P/IV3.00
Premium +216% Return to IV: -68.3%
Market implies +22.3%/yr vs model +23.3% · in line
VSTM
Verastem, Inc.
Deeply overvalued
Healthcare Risk 62 · High
Price$7.34
Model IV$2.42
P/IV1.79
Premium +204% Return to IV: -67.1%
Market implies +15.7%/yr vs model +50.0% · below model
VTOL
Bristow Group Inc.
Deeply overvalued
Industrials Risk 64 · High
Price$42.70
Model IV$26.27
P/IV1.58
Premium +63% Return to IV: -38.5%
Market implies +11.0%/yr vs model +6.8% · above model
VTR
Ventas, Inc.
Deeply overvalued
Financial Services Risk 69 · High
Price$89.99
Model IV$48.99
P/IV1.72
Premium +84% Return to IV: -45.6%
VTSI
VirTra, Inc
Deeply overvalued
Consumer Cyclical Risk 63 · High
Price$2.98
Model IV$1.61
P/IV2.14
Premium +86% Return to IV: -46.1%
Market implies +7.5%/yr vs model +3.0% · above model
VVV
VALVOLINE INC
Deeply overvalued
Energy Risk 59 · Elevated
Price$30.55
Model IV$16.86
P/IV2.00
Premium +81% Return to IV: -44.8%
Market implies +14.4%/yr vs model +8.0% · above model
WAB
WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP
Deeply overvalued
Consumer Cyclical Risk 59 · Elevated
Price$278.42
Model IV$170.33
P/IV1.53
Premium +63% Return to IV: -38.8%
Market implies +15.7%/yr vs model +11.3% · above model
WAFU
Wah Fu Education Group Ltd
Deeply overvalued
Consumer Defensive Risk 61 · High
Price$1.38
Model IV$0.47
P/IV3.63
Premium +196% Return to IV: -66.2%
Market implies +5.5%/yr vs model +2.0% · above model
WAT
WATERS CORP /DE/
Deeply overvalued
Healthcare Risk 60 · High
Price$410.01
Model IV$153.22
P/IV2.50
Premium +168% Return to IV: -62.6%
Market implies +18.4%/yr vs model +6.2% · above model
WATT
Energous Corp
Deeply overvalued
Technology Risk 50 · Elevated
Price$11.33
Model IV$14.88
P/IV1.88
Discount 24% Return to IV: +31.3%
Market implies -0.7%/yr vs model +50.0% · below model
WCN
Waste Connections, Inc.
Deeply overvalued
Utilities Risk 59 · Elevated
Price$159.74
Model IV$44.91
P/IV3.32
Premium +256% Return to IV: -71.9%
WDFC
WD 40 CO
Deeply overvalued
Basic Materials Risk 59 · Elevated
Price$189.83
Model IV$126.24
P/IV1.58
Premium +50% Return to IV: -33.5%
Market implies +10.0%/yr vs model +5.8% · above model
WELL
WELLTOWER INC.
Deeply overvalued
Financial Services Risk 69 · High
Price$235.62
Model IV$73.78
P/IV2.78
Premium +219% Return to IV: -68.7%
WFCF
Where Food Comes From, Inc.
Deeply overvalued
Technology Risk 59 · Elevated
Price$13.20
Model IV$4.87
P/IV2.41
Premium +171% Return to IV: -63.1%
Market implies +19.6%/yr vs model +9.9% · above model
WGS
GeneDx Holdings Corp.
Deeply overvalued
Healthcare Risk 57 · Elevated
Price$85.27
Model IV$28.45
P/IV1.83
Premium +200% Return to IV: -66.6%
Market implies +15.5%/yr vs model +19.1% · below model
WINA
WINMARK CORP
Deeply overvalued
Consumer Cyclical Risk 63 · High
Price$308.47
Model IV$186.67
P/IV2.03
Premium +65% Return to IV: -39.5%
Market implies +10.0%/yr vs model +4.9% · above model
WING
Wingstop Inc.
Fairly valued
Consumer Cyclical Risk 58 · Elevated
Price$100.84
Model IV$114.94
P/IV1.37
Discount 12% Return to IV: +14.0%
Market implies +15.6%/yr vs model +21.7% · below model
WK
WORKIVA INC
Deeply overvalued
Technology Risk 52 · Elevated
Price$71.86
Model IV$12.44
P/IV4.00
Premium +478% Return to IV: -82.7%
Market implies +36.3%/yr vs model +16.8% · above model
WLDN
Willdan Group, Inc.
Deeply overvalued
Industrials Risk 63 · High
Price$82.20
Model IV$57.55
P/IV1.58
Premium +43% Return to IV: -30.0%
Market implies +15.6%/yr vs model +14.3% · in line
WLTH
WEALTHFRONT CORP
Deeply overvalued
Financial Services Risk 61 · High
Price$10.38
Model IV$6.81
P/IV1.80
Premium +52% Return to IV: -34.4%
Market implies +8.1%/yr vs model +29.8% · below model
WLY
JOHN WILEY & SONS, INC.
Deeply overvalued
Communication Services Risk 62 · High
Price$47.03
Model IV$31.23
P/IV1.35
Premium +51% Return to IV: -33.6%
Market implies +5.8%/yr vs model +0.6% · above model
WLYB
JOHN WILEY & SONS, INC.
Deeply overvalued
Communication Services Risk 55 · Elevated
Price$48.00
Model IV$31.23
P/IV1.31
Premium +54% Return to IV: -34.9%
Market implies +6.0%/yr vs model +0.6% · above model
WM
WASTE MANAGEMENT INC
Deeply overvalued
Utilities Risk 53 · Elevated
Price$218.09
Model IV$114.54
P/IV1.85
Premium +90% Return to IV: -47.5%
WMS
ADVANCED DRAINAGE SYSTEMS, INC.
Deeply overvalued
Consumer Cyclical Risk 63 · High
Price$127.88
Model IV$87.95
P/IV1.58
Premium +45% Return to IV: -31.2%
Market implies +8.9%/yr vs model +4.1% · above model
WOOF
Petco Health & Wellness Company, Inc.
Deeply overvalued
Consumer Cyclical Risk 57 · Elevated
Price$2.45
Model IV$0.89
P/IV3.37
Premium +174% Return to IV: -63.6%
Market implies +15.4%/yr vs model +3.0% · above model
WOR
WORTHINGTON ENTERPRISES, INC.
Deeply overvalued
Basic Materials Risk 65 · High
Price$55.25
Model IV$37.07
P/IV1.53
Premium +49% Return to IV: -32.9%
Market implies +3.5%/yr vs model +0.0% · above model
WPC
W. P. Carey Inc.
Deeply overvalued
Financial Services Risk 71 · High
Price$69.19
Model IV$52.70
P/IV1.41
Premium +31% Return to IV: -23.8%
WS
Worthington Steel, Inc.
Deeply overvalued
Basic Materials Risk 65 · High
Price$32.35
Model IV$19.24
P/IV2.19
Premium +68% Return to IV: -40.5%
Market implies +7.0%/yr vs model +0.0% · above model
WSM
WILLIAMS SONOMA INC
Deeply overvalued
Consumer Cyclical Risk 66 · High
Price$229.43
Model IV$86.77
P/IV2.35
Premium +164% Return to IV: -62.2%
Market implies +16.6%/yr vs model +3.0% · above model
WSO
WATSCO INC
Deeply overvalued
Industrials Risk 62 · High
Price$311.58
Model IV$182.31
P/IV2.01
Premium +71% Return to IV: -41.5%
Market implies +11.2%/yr vs model +4.3% · above model
WSR
Whitestone REIT
Deeply overvalued
Financial Services Risk 64 · High
Price$18.99
Model IV$13.00
P/IV1.47
Premium +46% Return to IV: -31.5%
WST
WEST PHARMACEUTICAL SERVICES INC
Deeply overvalued
Healthcare Risk 60 · High
Price$346.23
Model IV$123.32
P/IV2.62
Premium +181% Return to IV: -64.4%
Market implies +18.4%/yr vs model +5.7% · above model
WTS
WATTS WATER TECHNOLOGIES INC
Deeply overvalued
Industrials Risk 48 · Elevated
Price$350.47
Model IV$225.81
P/IV1.37
Premium +55% Return to IV: -35.6%
Market implies +11.8%/yr vs model +7.2% · above model
WW
WW INTERNATIONAL, INC.
Deeply overvalued
Consumer Cyclical Risk 70 · High
Price$14.78
Model IV$3.41
P/IV4.88
Premium +334% Return to IV: -76.9%
Market implies +24.6%/yr vs model +2.0% · above model
WWD
Woodward, Inc.
Deeply overvalued
Technology Risk 61 · High
Price$337.26
Model IV$107.01
P/IV3.27
Premium +215% Return to IV: -68.3%
Market implies +27.0%/yr vs model +13.8% · above model
WWW
WOLVERINE WORLD WIDE INC /DE/
Deeply overvalued
Consumer Cyclical Risk 63 · High
Price$19.12
Model IV$7.02
P/IV2.50
Premium +172% Return to IV: -63.3%
Market implies +8.2%/yr vs model -5.5% · above model
WY
WEYERHAEUSER CO
Deeply overvalued
Financial Services Risk 72 · High
Price$22.06
Model IV$11.43
P/IV2.14
Premium +93% Return to IV: -48.2%
WYY
WIDEPOINT CORP
Deeply overvalued
Technology Risk 45 · Elevated
Price$10.83
Model IV$8.06
P/IV1.40
Premium +34% Return to IV: -25.6%
Market implies +12.8%/yr vs model +13.8% · in line
XBIO
Xenetic Biosciences, Inc.
Deeply overvalued
Healthcare Risk 54 · Elevated
Price$3.90
Model IV$2.04
P/IV1.54
Premium +91% Return to IV: -47.7%
Market implies +7.6%/yr vs model +26.5% · below model